Market Insider

Stocks making the biggest moves after hours: KEYS, LZB, DLB

Check out the companies making headlines in extended trading: Keysight Technologies — Shares added more than 8%. The electronics test and measurement equipment company's fiscal fourth-quarter results beat analysts' estimates on the top and bottom lines. Keysight also issued a rosy outlook for the current quarter, anticipating adjusted earnings...

Market Insider

WMT, LOW, INTU, KHC and more

Check out the companies making headlines in midday trading: Walmart — The big-box retailer saw shares jump nearly 5% to hit a record after the retail giant topped fiscal third-quarter earnings and revenue expectations. The retailer also hiked its outlook again as it saw growth in e-commerce and improvements...

Popular Posts

Featured Posts

Featured Author

Gregg Greenberg spent 14 years as a journalist at TheStreet.com where he wrote the highly popular column "The 5 Dumbest Things on Wall Street This Week". His work has appeared in magazines ranging from Glamour to ESPN the Magazine, and on humor sites such as Points in Case.

Fintech Review

With years of experience dissecting and evaluating the evolving fintech landscape, Fintech Review has become a trusted name in providing insightful, comprehensive, and unbiased reviews of tech-related financial products and services. From the latest advancements in blockchain and cryptocurrencies to cutting-edge payment platforms, robo-advisors, and beyond, Fintech Review keeps a pulse on the innovations that are redefining the financial industry.

LCID, DFS, PPG and more

Check out the companies making headlines in extended trading: Discover Financial — Shares inched lower by 1%. The financial services company posted third-quarter results that surpassed expectations, with earnings of $3.69 per share on $4.45 billion of revenue. Analysts polled by LSEG were calling for earnings of $3.42 per...

UAL, MS, ASML, PLD and more

Check out the companies making headlines in midday trading: Novavax — Shares plunged more than 17% after the biotech company said the U.S. Food and Drug Administration put a clinical hold on its application for a Covid and influenza combination shot as well as a stand-alone flu vaccine. United...